Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators

Inoue, Kenichi; Ninomiya, Jun; Saito, Tsuyoshi; Kimizuka, Kei; Kurosumi, Masafumi

doi:10.1186/s12885-018-4556-6

BMC Cancer

Article metrics
Last updated: Fri, 26 Apr 2024 18:37:40 Z

Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators

Access & Citations

2160

Article Accesses
5

Web of Science
4

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com